Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



TANG CAPITAL PARTNERS LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/10/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 8.6% stake in Bionomics Limited
07/13/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 11% stake in ASLAN Pharmaceuticals Limited
06/06/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 6.1% stake in AVROBIO, Inc.
06/01/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.
Txns: Bought 347,932 shares @ $1.05, valued at $365.3k
Bought 200,000 shares @ $1, valued at $200k
Bought 32,890 shares @ $1.06, valued at $34.9k
Bought 2,016 shares @ $1.08, valued at $2.2k
Bought 5,930 shares @ $1.06, valued at $6.3k
Bought 161,180 shares @ $1.08, valued at $174.1k
Bought 5,000 shares @ $1.1, valued at $5.5k
Bought 92,984 shares @ $1.09, valued at $101.4k
Bought 240,341 shares @ $1.12, valued at $269.2k
06/01/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on Rain Oncology Inc.
06/01/2023 SC 13D TANG CAPITAL PARTNERS LP reports a 14.1% stake in Rain Oncology Inc.
05/30/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 50,000 shares @ $1.72, valued at $86k
05/15/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 38,765 shares @ $1.95, valued at $75.6k
Bought 6,183 shares @ $1.95, valued at $12.1k
05/10/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 57,073 shares @ $1.95, valued at $111.3k
Bought 20,141 shares @ $1.95, valued at $39.3k
Bought 6,774 shares @ $1.95, valued at $13.2k
05/05/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 18,513 shares @ $1.85, valued at $34.2k
Bought 104,241 shares @ $1.86, valued at $193.9k
Bought 95,759 shares @ $1.9, valued at $181.9k
Bought 71,064 shares @ $1.94, valued at $137.9k
05/05/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on TCR2 THERAPEUTICS INC.
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/17/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/31/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 10% stake in Quince Therapeutics, Inc.
03/28/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/17/2023 SC 13D/A TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc.
03/17/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 10% stake in Bellerophon Therapeutics, Inc.
03/14/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Bought 65,701 shares @ $0.994, valued at $65.3k
Bought 20,286 shares @ $1.018, valued at $20.7k
03/14/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on Jounce Therapeutics, Inc.
03/14/2023 SC 13D TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc.
03/13/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 5.3% stake in Adicet Bio, Inc.
03/06/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 9.7% stake in Jounce Therapeutics, Inc.
02/24/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 5.8% stake in Elevation Oncology, Inc.
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 0% stake in Corvus Pharmaceuticals, Inc.
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 5.3% stake in CytomX Therapeutics, Inc.
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 3.2% stake in Heron Therapeutics, Inc.
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 0% stake in Inspirato Incorporated
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 9.4% stake in KalVista Pharmaceuticals, Inc.
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 10% stake in Metacrine, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy